Dongwha Pharm.Co.,Ltd

Symbol: 000020.KS

KSC

8550

KRW

Market price today

  • 8.5058

    P/E Ratio

  • 0.0376

    PEG Ratio

  • 236.99B

    MRK Cap

  • 0.02%

    DIV Yield

Dongwha Pharm.Co.,Ltd (000020-KS) Stock Price & Analysis

Shares Outstanding

27.72M

Gross Profit Margin

0.52%

Operating Profit Margin

0.05%

Net Profit Margin

0.08%

Return on Assets

0.05%

Return on Equity

0.07%

Return on Capital Employed

0.04%

Company general description and statistics

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO:Mr. Doh Joon Yoon
Full-time employees:809
City:Seoul
Address:FastFive Tower
IPO:2000-01-04
CIK:

Dongwha Pharm Co., Ltd. manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxant/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and teeth, hepatic protector, nutrient, tonic, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics. The company was founded in 1897 and is based in Seoul, South Korea.

General Outlook

In simple terms, Dongwha Pharm.Co.,Ltd has 27.718 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.523% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.052%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.076%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.049% return, is a testament to Dongwha Pharm.Co.,Ltd's adeptness in optimizing resource deployment. Dongwha Pharm.Co.,Ltd's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.073%. Furthermore, the proficiency of Dongwha Pharm.Co.,Ltd in capital utilization is underscored by a remarkable 0.041% return on capital employed.

Stock Prices

Dongwha Pharm.Co.,Ltd's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $9510, while its low point bottomed out at $9400. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Dongwha Pharm.Co.,Ltd's stock market.

Liquidity Ratios

Analyzing 000020.KS liquidity ratios reveals its financial health of the firm. The current ratio of 223.96% gauges short-term asset coverage for liabilities. The quick ratio (152.37%) assesses immediate liquidity, while the cash ratio (68.14%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio223.96%
Quick Ratio152.37%
Cash Ratio68.14%

Profitability Ratios

000020.KS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 10.23% underscores its earnings before tax deductions. The effective tax rate stands at 23.59%, revealing its tax efficiency. The net income per EBT, 74.25%, and the EBT per EBIT, 196.82%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 5.20%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin10.23%
Effective Tax Rate23.59%
Net Income per EBT74.25%
EBT per EBIT196.82%
EBIT per Revenue5.20%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 2.24, it details the span from stock purchase to revenue. The 2 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 484.81% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding152
Days of Inventory Outstanding150
Operating Cycle225.11
Days of Payables Outstanding67
Cash Conversion Cycle159
Receivables Turnover4.85
Payables Turnover5.48
Inventory Turnover2.44
Fixed Asset Turnover1.92
Asset Turnover0.64

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 1052.27, and free cash flow per share, 101.78, depict cash generation on a per-share basis. The cash per share value, 3147.21, showcases liquidity position. A payout ratio of 0.18 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.08, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share1052.27
Free Cash Flow per Share101.78
Cash per Share3147.21
Payout Ratio0.18
Operating Cash Flow Sales Ratio0.08
Free Cash Flow to Operating Cash Flow Ratio0.10
Cash Flow Coverage Ratio0.80
Short Term Coverage Ratio1.43
Capital Expenditure Coverage Ratio1.11
Dividend Paid and Capex Coverage Ratio0.93
Dividend Payout Ratio0.02

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 6.46%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.10, we discern the balance between debt and equity financing. The long-term debt to capitalization, 4.16%, and total debt to capitalization, 8.94%, ratios shed light on its capital structure. An interest coverage of -4.54 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio6.46%
Debt Equity Ratio0.10
Long Term Debt to Capitalization4.16%
Total Debt to Capitalization8.94%
Interest Coverage-4.54
Cash Flow to Debt Ratio0.80
Company Equity Multiplier1.52

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 13043.18, provides a glimpse into top-line earnings distributed across each share. Net income per share, 991.07, reflects the portion of profit attributed to each share. The book value per share, 13428.62, represents the net asset value distributed per share, while the tangible book value per share, 12672.20, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share13043.18
Net Income Per Share991.07
Book Value Per Share13428.62
Tangible Book Value Per Share12672.20
Shareholders Equity Per Share13428.62
Interest Debt Per Share1329.47
Capex Per Share-951.60

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 6.08%, indicates top-line expansion, while the gross profit growth, 1.73%, reveals profitability trends. EBIT growth, -37.24%, and operating income growth, -37.24%, offer insights into operational profitability progression. The net income growth, 34.61%, showcases bottom-line expansion, and the EPS growth, 34.58%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth6.08%
Gross Profit Growth1.73%
EBIT Growth-37.24%
Operating Income Growth-37.24%
Net Income Growth34.61%
EPS Growth34.58%
EPS Diluted Growth34.58%
Weighted Average Shares Growth0.02%
Weighted Average Shares Diluted Growth0.02%
Dividends per Share Growth-0.02%
Operating Cash Flow Growth-0.19%
Free Cash Flow Growth-69.10%
10-Year Revenue Growth per Share66.46%
5-Year Revenue Growth per Share17.35%
3-Year Revenue Growth per Share32.35%
10-Year Operating CF Growth per Share260.88%
5-Year Operating CF Growth per Share766.51%
3-Year Operating CF Growth per Share-44.31%
10-Year Net Income Growth per Share2652.96%
5-Year Net Income Growth per Share171.53%
3-Year Net Income Growth per Share-4.02%
10-Year Shareholders Equity Growth per Share66.10%
5-Year Shareholders Equity Growth per Share24.68%
3-Year Shareholders Equity Growth per Share11.92%
10-Year Dividend per Share Growth per Share126.36%
5-Year Dividend per Share Growth per Share19.87%
3-Year Dividend per Share Growth per Share49.96%
Receivables Growth2.54%
Inventory Growth51.12%
Asset Growth22.52%
Book Value per Share Growth2.00%
Debt Growth624.12%
R&D Expense Growth5.63%
SGA Expenses Growth87.36%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 266,360,334,945, captures the company's total value, considering both debt and equity. Income quality, 1.06, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.04, gauges operational efficiency, while the research and development to revenue, 5.64%, highlights investment in innovation. The ratio of intangibles to total assets, 10.00%, indicates the value of non-physical assets, and capex to operating cash flow, -90.33%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value266,360,334,945
Income Quality1.06
Sales General and Administrative to Revenue0.04
Research and Development to Revenue5.64%
Intangibles to Total Assets10.00%
Capex to Operating Cash Flow-90.33%
Capex to Revenue-7.30%
Capex to Depreciation-189.59%
Stock-Based Compensation to Revenue0.02%
Graham Number17304.47
Return on Tangible Assets5.40%
Graham Net Net750.90
Working Capital131,566,183,582
Tangible Asset Value350,837,725,487
Net Current Asset Value80,043,175,086
Average Receivables73,561,254,131.5
Average Payables26,822,033,500
Average Inventory58,740,412,945
Days Sales Outstanding75
Days Payables Outstanding65
Days of Inventory On Hand146
ROIC3.51%
ROE0.07%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.63, and the price to book ratio, 0.63, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.65, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 82.73, and price to operating cash flows, 8.00, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.63
Price to Book Ratio0.63
Price to Sales Ratio0.65
Price Cash Flow Ratio8.00
Price Earnings to Growth Ratio0.04
Enterprise Value Multiple1.81
Price Fair Value0.63
Price to Operating Cash Flow Ratio8.00
Price to Free Cash Flows Ratio82.73
Price to Tangible Book Ratio0.78
Enterprise Value to Sales0.74
Enterprise Value Over EBITDA14.19
EV to Operating Cash Flow9.13
Earnings Yield9.45%
Free Cash Flow Yield0.97%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Dongwha Pharm.Co.,Ltd (000020.KS) on the KSC in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 8.506 in 2024.

What is the ticker symbol of Dongwha Pharm.Co.,Ltd stock?

The ticker symbol of Dongwha Pharm.Co.,Ltd stock is 000020.KS.

What is company IPO date?

IPO date of Dongwha Pharm.Co.,Ltd is 2000-01-04.

What is company current share price?

Current share price is 8550.000 KRW.

What is stock market cap today?

The market cap of stock today is 236988558000.000.

What is PEG ratio in 2024?

The current 0.038 is 0.038 in 2024.

What is the number of employees in 2024?

In 2024 the company has 809.